Abstract:Purpose: To determine the feasibility of using radiofrequency hyperthermia (RFH) and to enhance the therapeutic effect of herpes simplex virus-thymidine kinase/ganciclovir (HSV-TK/GCV) for the treatment of hepatocellular carcinoma (HCC).Materials and methods: Human HCC cells (HepG2) were first transfected with lentivirus/luciferase. For both in vitro confirmation and in vivo validation, luciferase-labeled HCC cells and HCC tumour xenografts on mice received different treatments: (i) combination therapy of intratumoral HSV-TK/GCV-mediated gene therapy plus magnetic resonance imaging heating guidewire (MRIHG)-mediated RFH; (ii) gene therapy only; (iii) RFH only; and (iv) phosphate-buffered saline (PBS) as control. Cell proliferation was quantified. Tumour changes were monitored by ultrasound imaging and bioluminescence optical imaging before and at days 7 and 14 after treatments, which were correlated with subsequent histology.Results:In vitro, the lowest cell proliferation was seen in the combination therapy group compared with control groups (296% vs. 56 +/- 9%, 93 +/- 4%, and 100 +/- 5%, p<.05). Ultrasound imaging of treated animal xenografts showed smaller relative tumour volume in combination therapy group than those in three control groups (0.74 +/- 0.19 vs. 1.79 +/- 0.24, 3.14 +/- 0.49 and 3.22 +/- 0.52, p<.05). Optical imaging demonstrated significant decrease of bioluminescence signals of tumours in the combination therapy group, compared to those in three control groups (1.2 +/- 0.1 vs. 1.9 +/- 0.2% vs. 3.3 +/- 0.6% vs. 3.5 +/- 0.4%, p<.05). These imaging findings were correlated well with histologic confirmation.Conclusion: RFH can enhance HSV-TK/GCV-mediated gene therapy of HepG2 cell line and mice human HCC xenografts, which may open new avenues for effective management of HCC using MR/RFH integrated interventional gene therapy.

Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy for experimental prostate cancer

Killing effect of mutant herpes simplex virus type 1 thymidine kinase on rat C6 glioma cells

Retrovirus-mediated HSV1-tk Gene Therapy for Androgen-Independent Prostate Cancer

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

Adenovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Combined with Ganciclovir Induces Hepatoma Cell Apoptosis

[Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell]

Inhibitory effect of ultrasound microbubbles carrying HSV_1-TK gene combined with ganciclovir on prostate cancer cells

In Situ Prostate Cancer Gene Therapy Using a Novel Adenoviral Vector Regulated by the Caveolin-1 Promoter.

Combination Effect of Oncolytic Adenovirus Therapy and Herpes Simplex Virus Thymidine Kinase/ganciclovir in Hepatic Carcinoma Animal Models.

Dially Trisulfide Enhancing Killing Effects of Herpes Simplex Virus Thymidine Kinase / Ganciclovir System Against Prostate Cancer Cells

[Toxic Effects of HSV-TK and CD-TK Suicidal Gene Systems on Prostate Carcinoma Cells].

[Experimental Study on Human Pulmonary Adenocarcinoma Cell A549 Transfected with HSV₁-TK Gene in Vitro and in Vivo].

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

HSV-tk Gene Delivered by Chitosan Nanoparticles Killed Prostate Cancer Cells in Vitro

In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line

Generation 5 polyamidoamine dendrimers-mediated experimental HSV-tk gene therapy in murine prostate cancer models

Adenovirus-mediated HSV-tk Gene Therapy for Experimental Human Bladder Cancer

Study of Adenoviral-Mediated Gene Therapy for Bladder Cancer Cell

Adenovirus-mediated TK Gene Combined with Α-Ifn in Treatment of Nude Mice Transplanted with Human Renal Clear-Cell Carcinoma

[Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transference and Combined Drug Therapy Leads to Apoptosis of Human Epithelial Ovarian Cancer Cells].

Experimented Gene Therapy for Prostate Cancer with HSV-TK/GCV System